Skip to main content
Article
Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab.
Cancer Research (2015)
  • Yoshinobu Koguchi, Providence Portland Medical Center
  • Helena M. Hoen
  • Shelly A. Bambina, University of Pennsylvania
  • Michael D. Rynning
  • Richard K. Fuerstenberg
  • Brendan D. Curti, Providence Portland Medical Center
  • Walter J. Urba
  • Christina Milburn, Bristol-Myers Squibb
  • Frances Rena Bahjat, Bristol-Myers Squibb
  • Alan J. Korman, Bristol-Myers Squibb
  • Keith S. Bahjat, Providence Portland Medical Center
Publication Date
December 1, 2015
DOI
10.1158/0008-5472.CAN-15-2303
Citation Information
Yoshinobu Koguchi, Helena M. Hoen, Shelly A. Bambina, Michael D. Rynning, et al.. "Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab." Cancer Research Vol. 75 Iss. 23 (2015) p. 5084 - 5092
Available at: http://works.bepress.com/walter-urba/117/